Compare Summit Therapeutics Inc (SMMT) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Williams Companies Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Williams Companies Inc trades at $73.43 (market cap $90.70B). The key difference: Williams Companies Inc is far larger — about 8.7× Summit Therapeutics Inc's market cap, and Williams Companies Inc pays a 2.83% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | WMB | |
|---|---|---|
Market Cap | $10.48B | $90.70B |
Sector | Health | Energy |
52-Week High | $29.32 | $79.40 |
52-Week Low | $13.05 | $56.51 |
Enterprise Value | $9.90B | $120.08B |
Dividend Yield | — | 2.83% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
